SCHEMBL4036242

SCHEMBL4036242

Nc1nc[nH]c2c3ccccc3cc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F12 P00748 1/20 0.39
PLAU P00749 1/20 0.39
NCF1 P14598 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
BACE1 P56817 1/20 0.39
ALDH1A1 P00352 3/20 0.35
PI4KA P42356 2/20 0.35
PI4K2B Q8TCG2 2/20 0.35
PI4K2A Q9BTU6 2/20 0.35
PI4KB Q9UBF8 2/20 0.35
POLB P06746 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NISCH Q9Y2I1 1/20 0.35
KDM4E B2RXH2 3/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5580019 0.69 DCPS (0.43) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL647671 0.68 NISCH (0.40) ALDH1A1NISCHKDM4EMAPTHPGD
Hydrochloric Acid SCHEMBL6448208 0.67 NISCH (0.39) ALDH1A1NISCHKDM4EMAPTHPGD
Hydrochloric Acid SCHEMBL645055 0.67 NISCH (0.39) ALDH1A1NISCHKDM4EMAPTHPGD
SCHEMBL4814372 0.64 ADORA2A (0.51) ALDH1A1POLBKDM4EMAPTHPGD
SCHEMBL23412386 0.64 F12 (0.46) F12PLAUNCF1NOS3NOS1
SCHEMBL27824941 0.63 CYP3A4 (0.61) ALDH1A1POLBRXFP1NISCHKDM4E
SCHEMBL28283371 0.63 ALDH1A1 (0.51) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL17047970 0.62 DCPS (0.43) ALDH1A1PI4KAPI4K2BPI4K2API4KB
SCHEMBL7517293 0.62 IDO1 (0.41) ALDH1A1PI4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673354-B1 ARYLINDENOPYRIDINES AND ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-04-22 EP disclosed